Medicare drug price negotiations may have a muted impact on drugmakers in the near term

By CNBC
| August 30, 2023

Analysts say the drug price talks will likely have a muted financial impact on manufacturers, at least for this first round of prescription medicines.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...